Cornelis Smit

606 total citations
22 papers, 424 citations indexed

About

Cornelis Smit is a scholar working on Pharmacology, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Cornelis Smit has authored 22 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 6 papers in Infectious Diseases and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Cornelis Smit's work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Pharmaceutical studies and practices (6 papers) and Antifungal resistance and susceptibility (3 papers). Cornelis Smit is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (10 papers), Pharmaceutical studies and practices (6 papers) and Antifungal resistance and susceptibility (3 papers). Cornelis Smit collaborates with scholars based in Netherlands, United States and Switzerland. Cornelis Smit's co-authors include Catherijne A. J. Knibbe, Roger J. M. Brüggemann, Sjoerd de Hoogd, Roeland E. Wasmann, Eric P.A. van Dongen, Mariska Y. M. Peeters, John van den Anker, Sebastiaan C. Goulooze, Johan W. Mouton and Tan Zhang and has published in prestigious journals such as Clinical Infectious Diseases, Pharmaceutical Research and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Cornelis Smit

20 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cornelis Smit Netherlands 12 177 126 90 79 54 22 424
Max Taubert Germany 13 207 1.2× 87 0.7× 39 0.4× 93 1.2× 66 1.2× 42 478
María Victoria Martínez Calvo Spain 14 299 1.7× 147 1.2× 80 0.9× 144 1.8× 27 0.5× 44 620
Kyle Matschke United States 15 83 0.5× 96 0.8× 57 0.6× 57 0.7× 41 0.8× 60 545
Dawn Harper United States 8 115 0.6× 78 0.6× 59 0.7× 44 0.6× 49 0.9× 9 375
Nicole R. Zane United States 12 111 0.6× 85 0.7× 80 0.9× 79 1.0× 59 1.1× 21 364
Michel Lavit France 14 186 1.1× 95 0.8× 55 0.6× 133 1.7× 34 0.6× 36 643
Chenyan Zhao China 13 94 0.5× 57 0.5× 57 0.6× 136 1.7× 20 0.4× 24 453
Samuel Maldonado United States 8 105 0.6× 69 0.5× 68 0.8× 113 1.4× 27 0.5× 13 354
Benito García Spain 12 158 0.9× 157 1.2× 67 0.7× 90 1.1× 15 0.3× 31 370
Roeland E. Wasmann South Africa 14 166 0.9× 230 1.8× 78 0.9× 124 1.6× 32 0.6× 40 403

Countries citing papers authored by Cornelis Smit

Since Specialization
Citations

This map shows the geographic impact of Cornelis Smit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelis Smit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelis Smit more than expected).

Fields of papers citing papers by Cornelis Smit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cornelis Smit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelis Smit. The network helps show where Cornelis Smit may publish in the future.

Co-authorship network of co-authors of Cornelis Smit

This figure shows the co-authorship network connecting the top 25 collaborators of Cornelis Smit. A scholar is included among the top collaborators of Cornelis Smit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cornelis Smit. Cornelis Smit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mitrović, Darko, et al.. (2025). Digoxin toxicity with therapeutic serum digoxin concentrations. Toxicology Reports. 15. 102079–102079.
2.
Krekels, Elke H. J., et al.. (2023). How to Dose Vancomycin in Overweight and Obese Patients with Varying Renal (Dys)function in the Novel Era of AUC 400–600 mg·h/L-Targeted Dosing. Clinical Pharmacokinetics. 63(1). 79–91. 4 indexed citations
3.
Smit, Cornelis, et al.. (2023). Vancomycin Clearance in Obese Adults is not Predictive of Clearance in Obese Adolescents. Clinical Pharmacokinetics. 62(5). 749–759. 5 indexed citations
4.
Smit, Cornelis, Samira Samiee‐Zafarghandy, Sinno H. P. Simons, et al.. (2022). Oral Ibuprofen Is More Effective than Intravenous Ibuprofen for Closure of a Patent Ductus Arteriosus: Can Pharmacokinetic Modeling Help Us to Understand Why?. Neonatology. 120(1). 81–89. 4 indexed citations
5.
Smit, Cornelis, Roeland E. Wasmann, Paul D. van der Linden, et al.. (2022). Ciprofloxacin Pharmacokinetics After Oral and Intravenous Administration in (Morbidly) Obese and Non-obese Individuals: A Prospective Clinical Study. Clinical Pharmacokinetics. 61(8). 1167–1175. 15 indexed citations
6.
Zhang, Tan, et al.. (2022). Drug pharmacokinetics in the obese population: challenging common assumptions on predictors of obesity-related parameter changes. Expert Opinion on Drug Metabolism & Toxicology. 18(10). 657–674. 26 indexed citations
7.
Smit, Cornelis, Sebastiaan C. Goulooze, Roger J. M. Brüggemann, Catherine M.T. Sherwin, & Catherijne A. J. Knibbe. (2021). Dosing Recommendations for Vancomycin in Children and Adolescents with Varying Levels of Obesity and Renal Dysfunction: a Population Pharmacokinetic Study in 1892 Children Aged 1–18 Years. The AAPS Journal. 23(3). 53–53. 13 indexed citations
8.
Smit, Cornelis, Daniela Hofmann, Somphou Sayasone, Jennifer Keiser, & Marc Pfister. (2021). Characterization of the Population Pharmacokinetics of Moxidectin in Adults Infected with Strongyloides Stercoralis: Support for a Fixed-Dose Treatment Regimen. Clinical Pharmacokinetics. 61(1). 123–132. 6 indexed citations
9.
Hofmann, Daniela, Cornelis Smit, Somphou Sayasone, Marc Pfister, & Jennifer Keiser. (2021). Optimizing moxidectin dosing for Strongyloides stercoralis infections: Insights from pharmacometric modeling. Clinical and Translational Science. 15(3). 700–708. 11 indexed citations
10.
Samiee‐Zafarghandy, Samira, Gerhard Fusch, Marc Pfister, et al.. (2021). Novel strategy to personalise use of ibuprofen for closure of patent ductus arteriosus in preterm neonates. Archives of Disease in Childhood. 107(1). 86–91. 4 indexed citations
11.
Smit, Cornelis, et al.. (2020). Dose recommendations for gentamicin in the real-world obese population with varying body weight and renal (dys)function. Journal of Antimicrobial Chemotherapy. 75(11). 3286–3292. 14 indexed citations
12.
Smit, Cornelis, Mariska Y. M. Peeters, John van den Anker, & Catherijne A. J. Knibbe. (2020). Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties. Clinical Pharmacokinetics. 59(6). 659–669. 47 indexed citations
13.
Smit, Cornelis, Roeland E. Wasmann, Sebastiaan C. Goulooze, et al.. (2019). Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals. British Journal of Clinical Pharmacology. 86(2). 303–317. 37 indexed citations
14.
Wasmann, Roeland E., Cornelis Smit, Eric P.A. van Dongen, et al.. (2019). Implications for IV posaconazole dosing in the era of obesity. Journal of Antimicrobial Chemotherapy. 75(4). 1006–1013. 22 indexed citations
15.
Wasmann, Roeland E., Cornelis Smit, Jill Adler‐Moore, et al.. (2019). Fixed Dosing of Liposomal Amphotericin B in Morbidly Obese Individuals. Clinical Infectious Diseases. 70(10). 2213–2215. 13 indexed citations
16.
Smit, Cornelis, Roeland E. Wasmann, Sebastiaan C. Goulooze, et al.. (2019). A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients. Clinical Pharmacokinetics. 58(10). 1333–1343. 16 indexed citations
17.
Smit, Cornelis, Roeland E. Wasmann, Marinus J. Wiezer, et al.. (2019). Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Non-obese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study. Pharmaceutical Research. 36(8). 112–112. 14 indexed citations
18.
Wasmann, Roeland E., Cornelis Smit, Rob ter Heine, et al.. (2018). Pharmacokinetics and probability of target attainment for micafungin in normal-weight and morbidly obese adults. Journal of Antimicrobial Chemotherapy. 74(4). 978–985. 23 indexed citations
19.
Smit, Cornelis, et al.. (2018). Intravitreal aflibercept versus intravitreal ranibizumab in patients with age-related macular degeneration: a comparative effectiveness study. Journal of Comparative Effectiveness Research. 7(6). 561–567. 3 indexed citations
20.
Smit, Cornelis, Sjoerd de Hoogd, Roger J. M. Brüggemann, & Catherijne A. J. Knibbe. (2018). Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters. Expert Opinion on Drug Metabolism & Toxicology. 14(3). 275–285. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026